12/11/2020
Amemdment no. 2 to the Universal Registration Document 2019
12/11/2020
Securities Note
12/11/2020
Bordereau d'amendement n° D. 20-0339-A02 du 11 décembre 2020
12/11/2020
Nanobiotix Code of Business Conduct and Ethics
12/11/2020
Appointment and compensation committee charter and internal rules of procedure
12/11/2020
Audit committee charter and internal rules of procedure
11/20/2020
Bordereau d'amendement n° D. 20-0339-A01 du 20 nov 2020
11/20/2020
Amemdment to the Universal Registration Document 2019
09/04/2020
Half-Year Financial Report 2020 (in French)
05/13/2020
Universal Registration Document 2019 - May 12, 2020 (R20-010)
02/21/2020
Expanded Access Policy
05/02/2019
Reference document 2018 (in French)
03/30/2018
Annual Financial Report 2017 (in French)
04/30/2016
Annual Financial Report 2015 (in French)
08/30/2015
Half-Year Financial Report 2015 (in French)
04/30/2015
Annual Financial Report 2014 (in French)
08/30/2014
Half-Year Financial Report 2014 (in French)
02/20/2014
Note d'opération Visa14-050 20 février 2014
04/30/2014
Annual Financial Report 2013 (in French)
06/30/2013
Half-Year Financial Report 2013 (in French)
04/30/2013
Annual Financial Report 2012 (in French)
10/10/2012
Note d'Opération - Octobre 2012
09/10/2012
Document De Base enregistré le 10 sept 2012 I.12-043
